Dr. Tiina Urv is the new director of the Extramural Research Program in the Office of Rare Diseases Research (ORDR). She leads the Rare Diseases Clinical Research Network (RDCRN), a multidisciplinary national program. As the NCATS Program Director for RDCRN, Tiina collaborates with 10 NIH Institutes to manage 21 consortia and a central Data Management and Coordinating Center.
The creation of the Consortium of Eosinophilic Gastrointestinal Disease Researchers (CEGIR) has changed the paradigm of collaborative efforts for eosinophilic gastrointestinal disorders.
The Rare Diseases Clinical Research Network (RDCRN) is sponsoring the 5th Conference on Clinical Research for Rare Diseases (CCRRD) on Thursday, October 4, 2018 in Washington, D.C.
The National Center for Advancing Translational Sciences (NCATS) at NIH is keenly interested in seeing more research studying rare diseases in which efforts and expertise are pooled across research groups and diseases to identify commonalities and shared targetable mechanisms. The intention is that such collaboration will increase efficiency and capacity in the development of new therapies compared to traditional approaches that focus within a single disease.
It is becoming increasingly clear that problems with some basic cellular processes can contribute to diseases affecting different organs. One cellular signaling pathway that appears to be involved in multiple diseases is the mTOR pathway.
Robert Desnick, PhD, MD, and Cynthia Tifft, PhD, MD, have been chosen by the National Organization for Rare Disorders (NORD) to receive 2017 Rare Impact Awards.
Projects supported under this program must involve collaboration with investigators from at least three different CTSA hubs and are intended to support the development of new technologies, methods or approaches to overcome roadblocks in translational science.